The U.S. government has moved up its estimate for when every adult in  America would have access to a vaccine, up to 01 May from the end of May previously. 

      • Nearly 2.5 million shots were administered on average in the last seven days. This compares with just over two million doses administered per day on average two weeks ago. So far, around 72 million people have received at least one vaccine dose. New Mexico, Alaska, and South Dakota lead the nation in doses per capita. 

      • At current pace, 50% of the population will have been at least partially vaccinated by mid-May, with herd immunity, estimated around 70%, reached in late June. These projections continue to improve as more vaccine supply reaches states. 

      • Maryland-based Novavax reported strong results for it's vaccine from trials in the UK and South Africa. It had an efficacy rate of 96 percent against the original coronavirus strain but just 55 percent against the more contagious variant found in South Africa. The company is working to tailor a new version of the vaccine to combat emerging variants. Authorization by the FDA could come in May, after U.S. trial results are released in April. 

For the latest United States case counts, click here.

COVID Map 3.17

17 march usa fax graph

17 shots chart

Latest global updates:
      • Several European countries, including Germany, France, Italy, Ireland, Spain, Denmark, Iceland, and Norway suspended the use of the Oxford-AstraZeneca vaccine amid concerns over increased risk of blood clots.

      • The WHO and European Union regulators say there is currently no indication the vaccine is the cause of the blood clots and recommend its continued use. AstraZeneca has said that there have been just 37 reports of blood clots among the more than 17 million people immunized with its drug.

      • Brazil gave full approval to the AstraZeneca vaccine. 

      • The European Medicines Agency announced on 04 March that they were reviewing Russia's Sputnik V vaccine for use in the bloc, in an effort to speed up vaccination across the continent. 

      • For the latest Global case counts, click here.


Header - GG Academy

GG Academy Email CourseUpdate v3-01 GG Academy Email CourseUpdate v3-02
In this course you will learn...
  • How to reduce the exposure and spread of COVID-19 at work, at home, and in public.
  • What changes you might encounter in the workplace due to COVID-19, and how it might affect your day-to-day activities.
  • Proactive steps to equip yourself with the resources and knowledge to be better prepared for changes to your work.
  • About the COVID-19 vaccine and how it is an effective way to stop the spread of COVID-19.

In this course you will learn...

  • How to build resilience, and the ways resilience helps us bounce back from challenging and traumatic events.
  • The ways we can manage stress, proven ways to build healthy habits and how to support both your well-being and the well-being of those you care about.
  • How planning and preparedness can lessen the impact of stress, anxiety and uncertainty.
  • Actions to take, so you, your family, and your household can be better prepared to manage a crisis.


Footer E Learning

Request Security

Subscribe Here
Sign up today to receive monthly articles curated by the Global Guardian team on relevant and important safety and security topics.